Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer



Status:Terminated
Conditions:Cervical Cancer, Cervical Cancer, Cancer, Cancer, Endometrial Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:November 2006
End Date:February 2008

Use our guide to learn which trials are right for you!

Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women

This study aims at developing an accurate, simple, and cost-effective method for screening
and early detection of uterine cancers

The present study aims at developing an accurate, simple and cost-effective method for
screening and early detection of uterine cancers in women using novel inventions and
biotechnology methods for collection and assay of uterine cells. Results of P2X7 assays
using tissues obtained from women with known uterine cancer and from women with
histologically normal endometrium will be compared. These data will also serve as basis for
future studies to test the predictive value of the method in population-based studies.

Inclusion Criteria:

- women scheduled to undergo hysterectomy

- ages 18 years and older

Exclusion Criteria:

- pregnant women

- students or employees under the direct supervision on the investigators.
We found this trial at
5
sites
Norfolk, Virginia 23507
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
Little Rock, Arkansas 72202
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dallas, Texas 75235
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Galveston, Texas 77555
?
mi
from
Galveston, TX
Click here to add this to my saved trials